🎉 Founding Member Beta — Join our Discord and get 3 months of Pro free. Learn more →

Aldeyra Therapeutics, Inc.

ALDX Healthcare
$0.644 +$0.01 (2.17%)
Market Cap: $38.84 M
Gurus Holding
3
Popularity Rank
#2821
% of Shares Held
7.57%
Net Activity (Q3 2026)
-$272,646.63

Guru Ownership Trend

Guru Analysis for Aldeyra Therapeutics, Inc. (ALDX)

Aldeyra Therapeutics, Inc. (ALDX), a key player in the Healthcare sector, continues to attract institutional attention.

As of Q2 2026, a total of 3 Super Investors (Gurus) hold positions in the company, with a combined stake valued at approximately $2.94 M.

Top institutional holders include Cliff Asness and Renaissance Technologies (RenTech).

Institutional sentiment is currently Slightly Bearish. This is evidenced by a $272,646.63 net outflow during the quarter.

Recent activity highlights Steven Cohen who opened a new position. Conversely, Renaissance Technologies (RenTech) reduced exposure by 25.1%.

Key Holders

Top 5 by Value

Top 5 by Conviction

Recent Activity Breakdown (Q3 2026)

+$0
Total Buy Value
New Buys 0
Additions 0
-$272,646.63
Total Sell Value
Reductions 1
Sold Out 0

Guru Consensus (Q3 2026)

Based on recent activity
Net Sellers
1
Net Buyers
0

FAQs for Aldeyra Therapeutics, Inc. (ALDX)

Major holders include Cliff Asness ($7.99 M), Renaissance Technologies (RenTech) ($812,213), Steven Cohen ($328,889). According to the latest reported data, 3 tracked investment managers collectively hold approximately 4.57 M shares.

According to the latest 13F reporting period, sentiment appears Bearish (Net Selling). There was a net outflow of $272,646.63, with 0 managers increasing positions and 1 managers reducing holdings.

During the most recent reporting period, 1 managers trimmed their positions, while 0 fully exited ALDX. The total reported sell value was $272,646.63.

No tracked managers opened new positions or increased their holdings in ALDX during the most recent reporting period.

Portfolio Manager % Portfolio Activity Shares Value Report Date
0.00% Add 32.6% 3,751,558 $7.99 M Q2 2026
0.00% Reduce -25.1% 660,336 $812,213 Q3 2026
0.00% New Buy 154,408 $328,889 Q2 2026
Date
Insider Name
Transaction
Value
Shares
Position / Chg
SEC Form